Antioxidant enzyme dysfunction in monocytes and CSF of Hispanic women with HIV-associated cognitive impairment

HIV-associated cognitive neurological disorders (HAND) prevail in the antiretroviral therapy era. Proteomics analysis of CSF revealed expression of Cu/Zn superoxide dismutase (Cu/Zn SOD) in Hispanic women with cognitive impairment (CI). We tested the hypothesis that there is reduced capacity of antioxidant enzymes in CI by measures of expression and activity of Cu/Zn SOD, catalase, and Se-glutathione peroxidase in HAND. Our results showed that the function of these antioxidants was decreased in the CSF and monocytes of women with CI. These findings have important implications regarding their possible contribution to oxidative stress and in the diagnosis and therapy for HAND.

[1]  G. Rotilio,et al.  Prolonged copper depletion induces expression of antioxidants and triggers apoptosis in SH-SY5Y neuroblastoma cells , 2003, Cellular and Molecular Life Sciences CMLS.

[2]  Howard E. Gendelman,et al.  CSF proteomic fingerprints for HIV-associated cognitive impairment , 2007, Journal of Neuroimmunology.

[3]  K. Williams,et al.  Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. , 2002, Annual review of neuroscience.

[4]  V. Wojna,et al.  Ethnicity and neuro-AIDS conditions in the HAART era. , 2009 .

[5]  A. Lackner,et al.  Perivascular Macrophages Are the Primary Cell Type Productively Infected by Simian Immunodeficiency Virus in the Brains of Macaques , 2001, The Journal of experimental medicine.

[6]  B. Rovin,et al.  HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Sidtis,et al.  Quinolinic acid in cerebrospinal fluid and serum in HIV‐1 Infection: Relationship to clinical and neurological status , 1991, Annals of neurology.

[8]  Soo‐Young Choi,et al.  Suppression of HIV-1 Tat-induced monocyte adhesiveness by a cell-permeable superoxide dismutase in astrocytes , 2007, Experimental & Molecular Medicine.

[9]  J. Becker,et al.  Response to systemic HIV viral load suppression correlates with psychomotor speed performance , 2003, Neurology.

[10]  Bruce J Brew,et al.  Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. , 2004, AIDS.

[11]  R. Cutler,et al.  Novel markers of oxidative stress in actively progressive HIV dementia , 2004, Journal of Neuroimmunology.

[12]  R. Schooley,et al.  Progressive increases in serum catalase activity in advancing human immunodeficiency virus infection. , 1992, Free radical biology & medicine.

[13]  W. Banks,et al.  HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells , 2005, Brain Research.

[14]  A. Nath,et al.  Pathobiology of Human Immunodeficiency Virus Dementia , 1999, Seminars in neurology.

[15]  M. Gougerot-Pocidalo,et al.  Oxidative stress in human immunodeficiency virus infection , 1997, Cellular and Molecular Life Sciences CMLS.

[16]  Spada,et al.  Decreased antioxidant defence in individuals infected by the human immunodeficiency virus , 2000, European journal of clinical investigation.

[17]  W. Dröge.  Free radicals in the physiological control of cell function. , 2002, Physiological reviews.

[18]  K. Marder,et al.  Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia , 2004, Neurology.

[19]  T. Fischer-Smith,et al.  Evolving paradigms in the pathogenesis of HIV-1-associated dementia , 2005, Expert Reviews in Molecular Medicine.

[20]  P. Ogunro,et al.  Plasma selenium concentration and glutathione peroxidase activity in HIV-1/AIDS infected patients: a correlation with the disease progression. , 2006, The Nigerian postgraduate medical journal.

[21]  R. Price,et al.  Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection , 1990, Annals of neurology.

[22]  S. J. Kim,et al.  Suppression of intracellular hydrogen peroxide generation and catalase levels in CD8+ T-lymphocytes from HIV+ individuals. , 1998, Free radical biology & medicine.

[23]  Colin L. Masters,et al.  Neurodegenerative diseases and oxidative stress , 2004, Nature Reviews Drug Discovery.

[24]  O. Selnes,et al.  Prevalence of human immunodeficiency virus-associated cognitive impairment in a group of Hispanic women at risk for neurological impairment , 2006, Journal of NeuroVirology.

[25]  E. Major,et al.  Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J T Becker,et al.  Biomarkers of HIV-1 CNS infection and injury , 2007, Neurology.

[27]  J. McArthur,et al.  Rate and Severity of HIV-Associated Dementia (HAD): Correlations with Gp41 and iNOS , 1999, Molecular medicine.

[28]  R. Ellis,et al.  Dynamics of monocyte chemoattractant protein type one (MCP-1) and HIV viral load in human cerebrospinal fluid and plasma , 2005, Journal of Neuroimmunology.

[29]  F. Bricaire,et al.  Neurodegenerative diseases and oxidative stress. , 2004, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[30]  M. Marikovsky,et al.  Cu/Zn Superoxide Dismutase Plays Important Role in Immune Response1 , 2003, The Journal of Immunology.

[31]  D. Griffin,et al.  Perspectives Series : Cytokines and the Brain Cytokines in the Brain during Viral Infection : Clues to HIV-associated Dementia , 1997 .

[32]  D. Kolson.  Neuropathogenesis of central nervous system HIV-1 infection. , 2002, Clinics in laboratory medicine.

[33]  K. Marder,et al.  Inter-rater reliability of a clinical staging of HIV-associated cognitive impairment , 2003, Neurology.

[34]  I. Grant,et al.  The monocyte chemotactic protein-1 -2578G allele is associated with elevated MCP-1 concentrations in cerebrospinal fluid , 2004, Journal of Neuroimmunology.

[35]  P. Portegies,et al.  Increased peroxynitrite activity in AIDS dementia complex: implications for the neuropathogenesis of HIV-1 infection. , 1999, Journal of immunology.

[36]  S. Westmoreland,et al.  CD163 identifies perivascular macrophages in normal and viral encephalitic brains and potential precursors to perivascular macrophages in blood. , 2006, The American journal of pathology.

[37]  M. McGrath,et al.  Unique monocyte subset in patients with AIDS dementia , 1997, The Lancet.

[38]  J. Becker,et al.  Updated research nosology for HIV-associated neurocognitive disorders , 2007, Neurology.

[39]  J. Julien,et al.  Wild‐type superoxide dismutase acquires binding and toxic properties of ALS‐linked mutant forms through oxidation , 2007, Journal of neurochemistry.

[40]  T. Reinhart,et al.  Neuroinvasion of Fluorescein-Positive Monocytes in Acute Simian Immunodeficiency Virus Infection , 2007, Journal of Virology.

[41]  Lynette M. Smith,et al.  Investigating the human immunodeficiency virus type 1-infected monocyte-derived macrophage secretome. , 2007, Virology.

[42]  Pascal Clayette,et al.  Oxidative stress and neuroAIDS: triggers, modulators and novel antioxidants , 2001, Trends in Neurosciences.

[43]  S. Croul,et al.  CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection , 2011, Journal of NeuroVirology.

[44]  H. Gendelman,et al.  Macrophage proteomic fingerprinting predicts HIV-1-associated cognitive impairment , 2003, Neurology.

[45]  A. Oratore,et al.  Proteins pattern alteration in AZT-treated K562 cells detected by two-dimensional gel electrophoresis and peptide mass fingerprinting , 2006, Proteome Science.